Leukocyte-Endothelial Adhesion in Tumor Immunity
Leukocyte-Endothelial Adhesion in Tumor Immunity
批准号:
8387717
负责人:
Sharon S Evans
金额:
$30.03万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-13 至 2015-11-30
关键词:
AddressAdhesionsAdhesivesAdoptive ImmunotherapyAdoptive TransferAntibodiesApoptosisAreaBlocking AntibodiesBloodBlood VesselsCD8B1 geneCXCL10 geneCXCR3 geneCell Adhesion MoleculesChemotactic FactorsCombined Modality TherapyCutaneous MelanomaCytolysisDevelopmentEndothelial CellsEnvironmentExtravasationFeverFrequenciesFundingGatekeepingGeneticGoalsGrowthHourHumanImageImmuneImmune responseImmunotherapyIn SituIntercellular adhesion molecule 1Interleukin-6InvestigationLaboratoriesLeadLeukocytesLinkLymphocyteMalignant - descriptorMediatingMicrospheresModelingMusOvalbuminPatientsPre-Clinical ModelPrior TherapyPropertyReactionRecruitment ActivityRegimenRoleSCID MiceSiteSpecimenStagingSystemT cell therapyT-LymphocyteTestingTissuesTranslatingTumor ImmunityTumor TissueVascular Endothelial CellWorkXenograft Modeladhesion receptorarmbasecancer immunotherapycancer therapychemokinechemokine receptorclinical practiceclinically relevantcombinatorialconditioningdensitydesignhuman diseaseimprovedinsightintravital microscopymelanomamigrationneoplastic cellnovelnovel strategiesnovel therapeuticspre-clinicalpreconditioningreceptorresponsesuccesstargeted deliverythermal stresstraffickingtumortumor growthtumor microenvironment
中文摘要
基于T细胞的癌症免疫疗法取决于血液传播的T细胞获得免疫应答的能力。
恶性组织,以启动肿瘤靶破坏。在扩大循环池的同时,
可以通过过继性T细胞转移在治疗上获得效应T细胞,
免疫治疗策略是有限的。我们的研究已经确定了一个缺乏贩运分子
T细胞进入肿瘤微环境所需的肿瘤微血管。但我们
已经发现肿瘤微环境可以被全身热疗法有利地利用
(STT)增加血管内皮细胞的粘附性,血管内皮细胞是肿瘤的通道,
组织中这些观察使我们假设全身热疗(STT)可以改善
通过靶向递送溶细胞性T淋巴细胞以治疗肿瘤的过继性T细胞疗法的功效
肿瘤生长的原发部位和转移部位。拟议的研究是根据以下方面拟订的:
在小鼠肿瘤模型中鉴定新的淋巴细胞-内皮细胞-白细胞介素-6(IL-6)轴,
介导STT的促粘附活性。STT的主要粘附靶点是血管守门人,
细胞间粘附分子-1(ICAM-1),其支持T细胞在血管壁上的牢固停滞,
跨内皮迁移。在目标1中,我们计划以我们以前的发现为基础,确定STT是否起作用
通过IL-6依赖性机制修饰另外的运输分子(粘附受体,
趋化因子),其在过继免疫疗法的鼠B16黑素瘤模型中募集T细胞。
补充的原位成像研究将调查内源性人IL-6在肿瘤中的作用。
在人黑素瘤的临床前异种移植模型中动员过继转移的T细胞。在目标2
我们将检验这样一个假设,即通过短暂的免疫调节对宿主组织环境进行预处理,
淋巴细胞耗竭增强STT对效应T细胞向小鼠黑色素瘤运输的作用
肿瘤组织这种多模式治疗对ICAM-1依赖性CD 8进入的组合效应
肿瘤组织中的效应T细胞将使用抗体阻断策略和粘附缺陷性T细胞来定义。
小鼠早期T细胞进入肿瘤组织和肿瘤细胞凋亡之间的因果关系将是
评估。目的3将检验局部趋化因子可用性增强对细胞增殖的影响的假设。
肿瘤血管景观可以与STT协同作用,增强CD 8 T细胞向肿瘤组织的运输
在收养转移中。趋化因子/趋化因子受体对,CXCL 10/CXCR 3,
在介导T细胞从最初的滚动相互作用到ICAM-1依赖的牢固停滞的转变中,
使用用于递送CXCL 10的缓释微球系统探测肿瘤血管。的
预期拟议的研究将为T细胞向肿瘤递送的机制提供新的见解
微环境,并为癌症免疫治疗中的新治疗策略提供概念基础。
英文摘要
T cell-based cancer immunotherapy depends on the ability of blood-borne T cells to gain access to
malignant tissues in order to initiate tumor-target destruction. While expansion of the pool of circulating
effector T cells can be achieved therapeutically by adoptive T cell transfer, the overall success of
immunotherapy strategies has been limited. Our studies have defined a paucity of trafficking molecules
on tumor microvessels that are required for T cell entry into the tumor microenvironment. However, we
have discovered that the tumor microenvironment can be exploited favorably by systemic thermal therapy
(STT) to increase the adhesive properties of vascular endothelial cells that serve as gateways to tumor
tissues. These observations lead us to hypothesize that systemic thermal therapy (STT) can improve
the efficacy of adoptive T cell therapy by targeting the delivery of cytolytic T lymphocytes to
primary and metastatic sites of tumor growth. The proposed studies are formulated on the basis of
the identification of a novel lymphocyte-endothelial-interleukin-6 (IL-6) axis in murine tumor models that
mediates the proadhesive activities of STT. A major adhesive target of STT is the vascular gatekeeper,
intercellular adhesion molecule-1 (ICAM-1), which supports both firm arrest of T cells on vessel walls and
transendothelial migration. In Aim 1 we plan to build on our previous findings to determine if STT acts
through an IL-6-dependent mechanism to modify additional trafficking molecules (adhesion receptors,
chemokines) that recruit T cells in a murine B16 melanoma model of adoptive immunotherapy.
Complementary in situ imaging studies will investigate the contribution of endogenous human IL-6 in
mobilizing adoptively transferred T cells in a preclinical xenograft model of human melanoma. In Aim 2
We will test the hypothesis that preconditioning of the host tissue environment by transient
lymphodepletion amplifies the effects of STT on the trafficking of effector T cells to murine melanoma
tumor tissues. The combinatorial effects of this multimodality therapy on ICAM-1-dependent entry of CD8
effector T cells in tumor tissues will be defined using antibody-blocking strategies and adhesion-deficient
mice. A causal relationship between early T cell entry into tumor tissues and tumor cell apoptosis will be
evaluated. Aim 3 will test the hypothesis that enhancement of the local chemokine availability on the
tumor vascular landscape can collaborate with STT to enhance CD8 T cell trafficking to tumor tissues
during adoptive transfer. The requirement for the chemokine/chemokine receptor pair, CXCL10/CXCR3,
in mediating the transition of T cells from initial rolling interactions to ICAM-1-dependent firm arrest in
tumor vessels will be probed using a sustained-release microsphere system for delivery of CXCL10. The
proposed studies are expected to provide new insights into mechanisms of T cell delivery to the tumor
microenvironment and offer a conceptual basis for novel therapeutic strategies in cancer immunotherapy.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1080/10739680802353850
发表时间:
2009-02
期刊:
Microcirculation (New York, N.Y. : 1994)
影响因子:
--
作者:
[Chen Q, Appenheimer MM, Muhitch JB, Fisher DT, Clancy KA, Miecznikowski JC, Wang WC, Evans SS]
通讯作者:
Evans SS
The Thoc1 encoded ribonucleoprotein is required for myeloid progenitor cell homeostasis in the adult mouse.
Thoc1 编码的核糖核蛋白是成年小鼠骨髓祖细胞稳态所必需的。
DOI:
10.1371/journal.pone.0097628
发表时间:
2014
期刊:
PloS one
影响因子:
3.7
作者:
[Pitzonka,Laura, Ullas,Sumana, Chinnam,Meenalakshmi, Povinelli,BenjaminJ, Fisher,DanielT, Golding,Michelle, Appenheimer,MichelleM, Nemeth,MichaelJ, Evans,Sharon, Goodrich,DavidW]
通讯作者:
Goodrich,DavidW
DOI:
10.1007/s12026-009-8122-9
发表时间:
2010-03
期刊:
Immunologic research
影响因子:
4.4
作者:
[Fisher DT, Vardam TD, Muhitch JB, Evans SS]
通讯作者:
Evans SS
DOI:
10.1080/2162402x.2015.1116675
发表时间:
2016-05
期刊:
Oncoimmunology
影响因子:
7.2
作者:
[Mikucki ME, Skitzki JJ, Frelinger JG, Odunsi K, Gajewski TF, Luster AD, Evans SS]
通讯作者:
Evans SS
DOI:
10.1038/ncomms10684
发表时间:
2016-02-17
期刊:
Nature communications
影响因子:
16.6
作者:
[Fisher DT, Muhitch JB, Kim M, Doyen KC, Bogner PN, Evans SS, Skitzki JJ]
通讯作者:
Skitzki JJ
共 7 条
Inflammatory Control of Lymphocyte Trafficking
-
批准号:8005710
-
项目类别:
-
资助金额:$46.71万
-
财政年份:2010
-
负责人:Sharon S Evans
-
依托单位:
Inflammatory Control of Lymphocyte Trafficking
-
批准号:7789702
-
项目类别:
-
资助金额:$46.53万
-
财政年份:2010
-
负责人:Sharon S Evans
-
依托单位:
Inflammatory Control of Lymphocyte Trafficking
-
批准号:8602800
-
项目类别:
-
资助金额:$48.74万
-
财政年份:2010
-
负责人:Sharon S Evans
-
依托单位:
Inflammatory Control of Lymphocyte Trafficking
-
批准号:8204839
-
项目类别:
-
资助金额:$47.37万
-
财政年份:2010
-
负责人:Sharon S Evans
-
依托单位:
Inflammatory Control of Lymphocyte Trafficking
-
批准号:8414884
-
项目类别:
-
资助金额:$45.16万
-
财政年份:2010
-
负责人:Sharon S Evans
-
依托单位:
Inflammatory Control of Lymphocyte Trafficking
-
批准号:7847761
-
项目类别:
-
资助金额:$25.61万
-
财政年份:2009
-
负责人:Sharon S Evans
-
依托单位:
LEUKOCYTE-ENDOTHELIAL CELL ADHESION IN TUMOR IMMUNITY
-
批准号:6475826
-
项目类别:
-
资助金额:$20.75万
-
财政年份:1999
-
负责人:Sharon S Evans
-
依托单位:
Leukocyte-Endothelial Adhesion in Tumor Immunity
-
批准号:8196824
-
项目类别:
-
资助金额:$31.5万
-
财政年份:1999
-
负责人:Sharon S Evans
-
依托单位:
Leukocyte-Endothelial Adhesion in Tumor Immunity
-
批准号:7742977
-
项目类别:
-
资助金额:$31.16万
-
财政年份:1999
-
负责人:Sharon S Evans
-
依托单位:
Leukocyte-Endothelial Adhesion in Tumor Immunity
-
批准号:6885338
-
项目类别:
-
资助金额:$33.17万
-
财政年份:1999
-
负责人:Sharon S Evans
-
依托单位:
Leukocyte-Endothelial Adhesion in Tumor Immunity
-
批准号:7232653
-
项目类别:
-
资助金额:$32.36万
-
财政年份:1999
-
负责人:Sharon S Evans
-
依托单位:
Leukocyte-Endothelial Adhesion in Tumor Immunity
-
批准号:6749014
-
项目类别:
-
资助金额:$32.72万
-
财政年份:1999
-
负责人:Sharon S Evans
-
依托单位:
Leukocyte-Endothelial Adhesion in Tumor Immunity
-
批准号:7992438
-
项目类别:
-
资助金额:$31.06万
-
财政年份:1999
-
负责人:Sharon S Evans
-
依托单位:
LEUKOCYTE-ENDOTHELIAL CELL ADHESION IN TUMOR IMMUNITY
-
批准号:6050909
-
项目类别:
-
资助金额:$19.97万
-
财政年份:1999
-
负责人:Sharon S Evans
-
依托单位:
Leukocyte-Endothelial Adhesion in Tumor Immunity
-
批准号:6681978
-
项目类别:
-
资助金额:$32.27万
-
财政年份:1999
-
负责人:Sharon S Evans
-
依托单位:
Leukocyte-Endothelial Adhesion in Tumor Immunity
-
批准号:7584704
-
项目类别:
-
资助金额:$31.16万
-
财政年份:1999
-
负责人:Sharon S Evans
-
依托单位:
Leukocyte-Endothelial Adhesion in Tumor Immunity
-
批准号:7062429
-
项目类别:
-
资助金额:$32.85万
-
财政年份:1999
-
负责人:Sharon S Evans
-
依托单位:
LEUKOCYTE-ENDOTHELIAL CELL ADHESION IN TUMOR IMMUNITY
-
批准号:6329055
-
项目类别:
-
资助金额:$20.15万
-
财政年份:1999
-
负责人:Sharon S Evans
-
依托单位:
XENOGENEIC MODEL FOR HOMING OF HUMAN LYMPHOCYTES
-
批准号:2284182
-
项目类别:
-
资助金额:$3.31万
-
财政年份:1993
-
负责人:Sharon S Evans
-
依托单位:
ROLE OF A-INTERFERON RECEPTOR IN HUMAN IMMUNOREGULATION
-
批准号:3458678
-
项目类别:
-
资助金额:$7.81万
-
财政年份:1988
-
负责人:Sharon S Evans
-
依托单位:
海外基金